HealthIT Answers January 23, 2022
Quris Closes $28 Million in Seed Funding From Top Institutional Investors
Quris, an artificial intelligence (AI) innovator disrupting the pharmaceutical arena, announced the final close of $28 million in seed funding – inclusive of the initial $9 million announced late last year with the launch of Quris’s BioAI platform for clinical prediction. Led by Welltech Ventures with participation from iAngels, GlenRock Capital, and others, the funding will fast-track Quris’s novel drug research and development, team expansion and partner-building efforts as it scales to rapidly scan 100s of drug candidates to train its AI engine in its mission to revolutionize the drug development process.
Castle Creek Biosciences Acquires Novavita Thera to Expand Innovative Cell and Gene Therapy Platform
Castle Creek Biosciences, Inc....
Today's Sponsors
Today's Sponsor